These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6691428)

  • 41. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
    Keck PE; Vuckovic A; Pope HG; Nierenberg AA; Gribble GW; White K
    J Clin Psychopharmacol; 1989 Jun; 9(3):203-6. PubMed ID: 2738182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anaphylaxis and monoamine oxidase inhibitors--the use of adrenaline.
    Fenwick MJ; Muwanga CL
    J Accid Emerg Med; 2000 Mar; 17(2):143-4. PubMed ID: 10718244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.
    Kayser A; Robinson DS; Yingling K; Howard DB; Corcella J; Laux D
    J Clin Psychopharmacol; 1988 Aug; 8(4):246-53. PubMed ID: 3062042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoamine oxidase inhibitors and sleep movements.
    Morgan JL; Brown TM; Wallace ER
    Am J Psychiatry; 1994 May; 151(5):782. PubMed ID: 8166329
    [No Abstract]   [Full Text] [Related]  

  • 46. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three cases of female anorgasmia associated with MAOIs.
    Lesko LM; Stotland NL; Segraves RT
    Am J Psychiatry; 1982 Oct; 139(10):1353-4. PubMed ID: 7124995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
    Merikangas KR; Merikangas JR
    Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MAOI-induced rapid cycling bipolar affective disorder in an adolescent.
    Mattsson A; Seltzer RL
    Am J Psychiatry; 1981 May; 138(5):677-9. PubMed ID: 6786112
    [No Abstract]   [Full Text] [Related]  

  • 52. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
    Sokolski KN; Brown BJ
    Ann Pharmacother; 2006 Mar; 40(3):567-70. PubMed ID: 16478812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenelzine use throughout pregnancy and the puerperium: case report, review of the literature, and management recommendations.
    Gracious BL; Wisner KL
    Depress Anxiety; 1997; 6(3):124-8. PubMed ID: 9442987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different effects of phenelzine treatment on EEG topography in waking and sleep in depressed patients.
    Landolt HP; Gillin JC
    Neuropsychopharmacology; 2002 Sep; 27(3):462-9. PubMed ID: 12225703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mysterious MAOI hypertensive episodes.
    Kahn D
    J Clin Psychiatry; 1988 Jan; 49(1):38-9. PubMed ID: 3335491
    [No Abstract]   [Full Text] [Related]  

  • 56. Serotonin syndrome probably triggered by a morphine-phenelzine interaction.
    Mateo-Carrasco H; Muñoz-Aguilera EM; García-Torrecillas JM; Abu Al-Robb H
    Pharmacotherapy; 2015 Jun; 35(6):e102-5. PubMed ID: 25903219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y; Karniel E; Szor H
    Isr J Psychiatry Relat Sci; 1996; 33(3):211-2. PubMed ID: 9009521
    [No Abstract]   [Full Text] [Related]  

  • 58. Management of monoamine oxidase inhibitor-associated insomnia with trazodone.
    Nierenberg AA; Keck PE
    J Clin Psychopharmacol; 1989 Feb; 9(1):42-5. PubMed ID: 2708555
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of antidepressant effect with long-term monoamine oxidase inhibitor treatment without loss of monoamine oxidase inhibition.
    Mann JJ
    J Clin Psychopharmacol; 1983 Dec; 3(6):363-6. PubMed ID: 6315778
    [No Abstract]   [Full Text] [Related]  

  • 60. Early and late side effects of phenelzine.
    Evans DL; Davidson J; Raft D
    J Clin Psychopharmacol; 1982 Jun; 2(3):208-10. PubMed ID: 7096609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.